2813 results
-
List item
Orphan designation: Ethyl Eicosapentaenoate for: Treatment of Huntington’s disease
Date of designation: 29/12/2000, Positive, Last updated: 04/01/2006Ethyl Eicosapent soft gelatin capsules: Withdrawn application Ethyl … Ethyl Eicosapent soft gelatin capsules: Orphan designation … Ethyl Eicosapent soft gelatin capsules Ethyl Eicosapent soft gelatin … -
List item
Withdrawn application: Ethyl Eicosapent soft gelatin capsules
date of withdrawal: 01/12/2009, Initial authorisation, Last updated: 08/12/2009Ethyl Eicosapent soft gelatin capsules: Withdrawn application … thyl Eicosapent soft gelatin capsules? e ethyl eicosapent. It … Ethyl Eicosapent soft gelatin capsules expected to oms of patients … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): purified diphtheria toxoid, Purified Tetanus Toxoid, Five component acellular pertussis [Purified Pertussis Toxoid (PT), Purified Filamentous Haemagglutinin (FHA), Purified Fimbriae Types 2 and 3 (FIM), and Purified Pertactin (PRN)], Inactivated poliomyelitis vaccine (Vero) – Type 1 (Mahoney), Type 2 (MEF-1) and Type 3 (Saukett), Purified polyribosylribitol phosphate capsular polysaccharide of Haemophilus influenzae type b covalently bound to Tetanus protein (PRP-T)
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Vaccines
PIP number: EMEA-000278-PIP01-08-M01, Route(s) of administration: Intramuscular use, Pharmaceutical form(s): Suspension for injection in pre-filled syringe, Suspension for injection in a vial
Decision date: 31/03/2009, Last updated: 18/05/2009, Compliance check: V, 18/09/2009polyribosylribitol phosphate capsular polysaccharide of Haemophilus … polyribosylribitol phosphate capsular polysaccharide of Haemophilus … polyribosylribitol phosphate capsular polysaccharide of Haemophilus … -
List item
Referral: Fluconazol Tiefenbacher 50mg, 100mg, 150mg, 200mg capsules, hard
fluconazole, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 24/07/2003, EC decision date: 01/12/2003, Last updated: 11/02/200450mg, 100mg, 150mg, 200mg capsules, hard … 50mg, 100mg, 150mg, 200mg capsules, hard … mg, 100 mg, 150 mg, 200 mg capsules, hard, INN-Fluconazole … -
List item
Referral: Diotop capsules
diclofenac, omeprazole, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 15/11/2018, EC decision date: 31/01/2019, Last updated: 15/02/2019Diotop capsules … diclofenac / omeprazole capsules) in the EU PDF icon application/pdf … About this medicineDiotop capsulesdiclofenacomeprazoleAbout this procedureEMEA/H/A-29(4)/1474 … -
List item
News: Public statement on supply of Norvir hard capsules
Last updated: 28/07/1998on supply of Norvir hard capsules … European Union (EU) as a hard capsule 100 mg and an oral solution … the manufacture of the hard capsule. The following is a summary … -
List item
Press release: European Medicines Agency agrees to precautionary recall of Advagraf 0.5 mg capsule batches
CHMP, Last updated: 20/10/2011recall of Advagraf 0.5 mg capsule batches … recall of Advagraf 0.5 mg capsule batches … recall of Advagraf 0.5 mg capsule batches 7 Westferry … -
List item
Press release: Amarin Neuroscience Ltd withdraws its marketing authorisation application for Ethyl Eicosapent Soft Capsules (ethyl eicosapent)
Last updated: 08/12/2009for Ethyl Eicosapent Soft Capsules (ethyl eicosapent … eicosapent), 500 mg soft gelatine capsules. Ethyl Eicosapent was expected … Ethyl Eicosapent Soft Gelatin Capsules and the state of the scientific … -
List item
Direct healthcare professional communication (DHPC): Risk of acute adrenal insufficiency when switching from crushed or compounded oral hydrocortisone formulations to Alkindi (hydrocortisone granules in capsules for opening)
Active substance: hydrocortisone, DHPC type: Safety signal, Last updated: 04/02/2021hydrocortisone granules in capsules for opening) Adrenal Insuffi … hydrocortisone granules in capsules for opening … hydrocortisone granules in capsules for opening) Dear … -
List item
Human medicine European public assessment report (EPAR): Zometa
zoledronic acid, zoledronic acid monohydrate, Cancer; Fractures, Bone
Date of authorisation: 20/03/2001, Revision: 36, Authorised, Last updated: 09/07/2021breaks in the bone), spinal compression (when the spinal cord is compressed by the bone), bone disorders … any fractures or any spinal compression. Zometa has also been compared … breaks in the bone), spinal compression (when the spinal cord is compressed by the bone), bone disorders … -
List item
Human medicine European public assessment report (EPAR): Zoledronic Acid Accord
zoledronic acid monohydrate, Hypercalcemia; Fractures, Bone; Cancer
Date of authorisation: 16/01/2014,
, Revision: 9, Authorised, Last updated: 24/01/2022
breaks in the bone), spinal compression (when the spinal cord is compressed by the bone), bone disorders … -
List item
Human medicine European public assessment report (EPAR): Zoledronic acid medac
zoledronic acid monohydrate, Fractures, Bone; Cancer
Date of authorisation: 03/08/2012,, Revision: 13, Authorised, Last updated: 20/11/2020
breaks in the bone), spinal compression (when the spinal cord is compressed by the bone), bone disorders … breaks in the bone), spinal compression (when the spinal cord is compressed by the bone), bone disorders … -
List item
Human medicine European public assessment report (EPAR): Zoledronic acid Actavis
zoledronic acid monohydrate, Fractures, Bone
Date of authorisation: 20/04/2012,, Revision: 15, Authorised, Last updated: 01/06/2023
breaks in the bone), spinal compression (when the spinal cord is compressed by the bone), bone disorders … breaks in the bone), spinal compression (when the spinal cord is compressed by the bone), bone disorders … pathological fractures, spinal compression, radiation or surgery to … -
List item
Human medicine European public assessment report (EPAR): Zoledronic Acid Hospira
zoledronic acid monohydrate, Hypercalcemia
Date of authorisation: 19/11/2012,, Revision: 18, Authorised, Last updated: 09/11/2021
breaks in the bone), spinal compression (when the spinal cord is compressed by the bone), bone disorders … breaks in the bone), spinal compression (when the spinal cord is compressed by the bone), bone disorders … -
List item
Human medicine European public assessment report (EPAR): Zoledronic acid Mylan
zoledronic acid, Fractures, Bone
Date of authorisation: 23/08/2012,, Revision: 14, Authorised, Last updated: 20/04/2023
breaks in the bone), spinal compression (when the spinal cord is compressed by the bone), bone disorders … breaks in the bone), spinal compression (when the spinal cord is compressed by the bone), bone disorders … -
List item
Human medicine European public assessment report (EPAR): Zoledronic acid Teva
zoledronic acid, Fractures, Bone; Cancer
Date of authorisation: 16/08/2012,, Revision: 14, Authorised, Last updated: 11/10/2021
breaks in the bone), spinal compression (when the spinal cord is compressed by the bone), bone disorders … breaks in the bone), spinal compression (when the spinal cord is compressed by the bone), bone disorders … pathological fractures, spinal compression, radiation or surgery to … -
List item
Human medicine European public assessment report (EPAR): VeraSeal
human fibrinogen, human thrombin, Hemostasis, Surgical
Date of authorisation: 10/11/2017, Revision: 7, Authorised, Last updated: 12/01/2023worked better than manual compression, with 76% of patients having … compared with 23% after manual compression (13 out of 57). In a second … intermittent application of compresses, swabs, use of suction devices … -
List item
Human medicine European public assessment report (EPAR): Evicel
human fibrinogen, human thrombin, Hemostasis, Surgical
Date of authorisation: 05/10/2008, Revision: 18, Authorised, Last updated: 11/05/2023compared Evicel with manual compression (applying direct pressure … received Evicel or manual compression. The second study compared … patients treated with manual compression (28 out of 72). During abdominal … -
List item
National expert: Stefanie Farrugia, Medicines Authority (updated)
- Declaration of interests - 40.11 KB | PDF
- Curriculum Vitae - 34.21 KB | PDF
-
List item
Human medicine European public assessment report (EPAR): IntronA
interferon alfa-2b, Carcinoid Tumor; Leukemia, Hairy Cell; Lymphoma, Follicular; Hepatitis B, Chronic; Hepatitis C, Chronic; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melanoma; Multiple Myeloma
Date of authorisation: 09/03/2000, Revision: 34, Withdrawn, Last updated: 15/12/2022major organ obstruction or compression syndrome, orbital or epidural … -
List item
Human medicine European public assessment report (EPAR): Exelon
rivastigmine, Dementia; Alzheimer Disease; Parkinson Disease
Date of authorisation: 11/05/1998, Revision: 46, Authorised, Last updated: 08/06/2023rivastigmine. It is available as capsules (1.5, 3, 4.5 and 6 mg), as … ability and behaviour. The capsules and oral solution can also … has side effects. Exelon capsules or oral solution should be … -
List item
Human medicine European public assessment report (EPAR): Atectura Breezhaler
indacaterol acetate, Mometasone furoate, Asthma
Date of authorisation: 30/05/2020, Revision: 9, Authorised, Last updated: 16/10/2023used? Atectura Breezhaler capsules, which contain a powder for … dose, the patient places a capsule into the inhaler and breathes … The recommended dose is one capsule, once a day at the same time … -
List item
Human medicine European public assessment report (EPAR): Bemrist Breezhaler
indacaterol, Mometasone furoate, Asthma
Date of authorisation: 30/05/2020, Revision: 6, Authorised, Last updated: 16/10/2023used? Bemrist Breezhaler capsules, which contain a powder for … dose, the patient places a capsule into the inhaler and breathes … The recommended dose is one capsule, once a day at the same time … -
List item
Human medicine European public assessment report (EPAR): Prometax (updated)
rivastigmine, Alzheimer Disease; Parkinson Disease; Dementia
Date of authorisation: 03/12/1998, Revision: 46, Authorised, Last updated: 21/11/2023rivastigmine. It is available as capsules (1.5, 3, 4.5 and 6 mg), as … ability and behaviour. The capsules and oral solution can also … has side effects. Prometax capsules or oral solution should be … -
List item
Human medicine European public assessment report (EPAR): Camcevi
leuprorelin mesilate, Prostatic Neoplasms
Date of authorisation: 24/05/2022, Revision: 1, Authorised, Last updated: 12/05/2023patients with spinal cord compression or those whose cancer has … patients with spinal cord compression or those whose cancer has …